- Report
- August 2025
- 371 Pages
Global
From €4351EUR$4,950USD£3,763GBP
- Report
- August 2025
- 188 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- September 2025
- 183 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- August 2025
- 182 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- November 2024
- 174 Pages
Global
From €3911EUR$4,450USD£3,383GBP
- Report
- July 2025
- 350 Pages
Global
From €4350EUR$4,949USD£3,763GBP
- Report
- March 2025
- 148 Pages
Global
From €2778EUR$3,160USD£2,403GBP
€3472EUR$3,950USD£3,003GBP
- Report
- May 2025
- 116 Pages
Global
From €4087EUR$4,650USD£3,535GBP
- Report
- August 2025
- 153 Pages
Global
From €2549EUR$2,900USD£2,205GBP
- Report
- June 2025
- 130 Pages
Global
From €3624EUR$4,123USD£3,134GBP
€4263EUR$4,850USD£3,687GBP
- Report
- May 2025
- 200 Pages
Global
From €3512EUR$3,995USD£3,037GBP
- Report
- June 2025
- 150 Pages
Global
From €5230EUR$5,950USD£4,524GBP
- Report
- August 2025
- 198 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- August 2025
- 190 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- August 2025
- 181 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- August 2025
- 194 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- August 2025
- 189 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- November 2024
- 180 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- October 2024
- 180 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- September 2025
- 108 Pages
Global
From €5142EUR$5,850USD£4,448GBP

The Human Microbiome market is a subset of the biotechnology industry that focuses on the study of the human microbiome. The human microbiome is the collection of microorganisms that live in and on the human body, and it plays an important role in human health. The Human Microbiome market is focused on understanding the role of the microbiome in health and disease, and developing products and services to improve human health. This includes the development of diagnostics, therapeutics, and probiotics.
The Human Microbiome market is driven by advances in technology, such as next-generation sequencing, which has enabled researchers to better understand the microbiome and its role in health and disease. Additionally, the increasing prevalence of chronic diseases, such as obesity and diabetes, has increased the demand for microbiome-based products and services.
Companies in the Human Microbiome market include uBiome, Second Genome, and Seres Therapeutics. Show Less Read more